KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 149 filers reported holding KURA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,174,623 | +328.7% | 111,023 | +455.1% | 0.02% | +425.0% |
Q3 2022 | $274,000 | -79.1% | 20,000 | -72.0% | 0.00% | -78.9% |
Q2 2022 | $1,311,000 | -55.9% | 71,518 | -61.3% | 0.02% | -48.6% |
Q1 2022 | $2,971,000 | -30.9% | 185,000 | -39.7% | 0.04% | -24.5% |
Q4 2021 | $4,297,000 | +282.3% | 306,800 | +411.3% | 0.05% | +308.3% |
Q3 2021 | $1,124,000 | +3.4% | 60,000 | +15.2% | 0.01% | -14.3% |
Q2 2021 | $1,087,000 | +17.3% | 52,100 | +83.5% | 0.01% | -33.3% |
Q4 2020 | $927,000 | – | 28,390 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |